Referenced in: none

Automatically associated channels: Kv1.5 , Slo1

Title: Synthesis of psoralen derivatives and their blocking effect of hKv1.5 channel.

Authors: Jae Soon Eun, Kwang Sik Kim, Han Na Kim, Seon Ah Park, Tian-Ze Ma, Kyung A Lee, Dae Keun Kim, Hyung Kyo Kim, In Su Kim, Young Hoon Jung, Ok Pyo Zee, Dong Jin Yoo, Yong Geun Kwak

Journal, date & volume: Arch. Pharm. Res., 2007 Feb , 30, 155-60

PubMed link: http://www.ncbi.nlm.nih.gov/pubmed/17366735

Abstract
Previously, we found that a furocoumarin derivative, psoralen (7H-furo[3,2-g][1]benzopyran-7-one), blocked a human Kv1.5 potassium channel (hKv1.5) and has a potential antiarrhythmic effect. In the present study, to develop more potent hKv1.5 blockers or antiarrhythmic drugs, we synthesized ten psoralen derivatives and examined their blocking effects on hKv1.5 stably expressed in Ltk cells. Among the newly synthesized psoralen derivatives, three derivatives (Compounds 5, 9 and 10) showed the open channel-blocking effect. Compound 9 among them was the most potent in blocking hKv1.5. We found that compound 9, one of the psoralen derivatives, inhibited the hKv1.5 current in a concentration-, use- and voltage-dependent manner with an IC50 value of 27.4 +/- 5.1 nM at +60 mV. Compound 9 accelerated the inactivation kinetics of the hKv1.5 channel, slowed the deactivation kinetics of hKv1.5 current resulting in a tail crossover phenomenon. Compound 9 inhibited hKv1.5 current in a use-dependent manner. These results indicate that compound 9, one of psoralen derivatives, acts on hKv1.5 channel as an open channel blocker and is much more potent than psoralen in blocking hKv1.5 channel. If further studies were done, compound 9 might be an ideal antiarrhythmic drug for atrial fibrillation.